High-yield points
- Drug resistance = failure of two appropriate medications. A third drug rarely works (about 11% after a first failure for lack of efficacy) .
- Refer early:
- as soon as drug resistance is established;
- or with a lesion in noneloquent cortex even if seizures are controlled .
- Evaluation within 1 year roughly doubles seizure freedom .
- An MRI lesion predicts intractability in childhood temporal lobe epilepsy . Onset in the first year carries the highest cognitive risk .
- Commonest pediatric substrates: cortical dysplasia (42%) and tumors (19%) .
- Expect:
- about 65% seizure-free at 1 year, falling over a decade;
- better results after hemispheric and temporal surgery and with complete resection ;
- surgery beats medication 77% vs. 7% .
Landmark papers
- Dwivedi et al., N Engl J Med 2017: pediatric randomized trial of surgery vs medical therapy. 77% of children were seizure-free at 12 months after surgery vs 7% on medical therapy .
- ILAE drug resistance definition (Kwan et al., Epilepsia 2010): consensus proposal defining drug resistance as seizure freedom not sustained despite adequate trials of two well-tolerated, appropriate antiseizure medications .
- Kwan and Brodie, N Engl J Med 2000: cohort of 525 newly diagnosed patients. Among the 470 previously untreated, 47% became seizure-free on the first drug, a further 14% on a second or third, and about 3% on two drugs together .
Epilepsy surgery is the most effective treatment for drug-resistant focal epilepsy in children, and it is underused and delayed.
- Randomized evidence: in a pediatric RCT, 77% of children were seizure-free at 12 months after surgery vs. 7% on medical therapy .
- Delay costs seizure freedom: in a US multicenter cohort, it was 53% vs. 27% when evaluation came within 1 year of drug resistance .
- This chapter:
- who is a candidate (drug resistance, and lesional epilepsy even before drug resistance);
- why to operate early;
- the etiologies neurosurgeons treat;
- what to expect.
- Procedure chapters: temporal, extratemporal, hemispheric, callosotomy, LITT, neuromodulation and mapping.
1. Drug-resistant epilepsy
- Definition (ILAE) :
- Seizure freedom not sustained despite adequate trials of two well-tolerated, appropriate antiseizure medications (the ILAE definition, paraphrased).
- Either way counts: the two schedules may be monotherapies or a combination.
- Little to gain from more drugs (525 newly diagnosed patients; percentages are of the 470 previously untreated) :
- First drug: 47% became seizure-free.
- Second or third drug: a further 14%.
- Two drugs together: about 3%.
- After a first drug failed for lack of efficacy: only 11% became seizure-free.
- How common in children (613 children with new epilepsy) :
- Overall: about 10% met criteria for intractable epilepsy early in their course.
- By syndrome: 34.6% of cryptogenic or symptomatic generalized epilepsies, but only 2.7% of idiopathic ones.
- Strongest predictor: initial seizure frequency.
- Lesions predict intractability. In children with new-onset temporal lobe epilepsy followed for a median of 14 years, every child with an MRI lesion remained not seizure-free. The lesions were hippocampal sclerosis, tumor and dysplasia .
- Refer lesional epilepsy before drug resistance :
- ILAE Surgical Therapies Commission consensus (61 experts, 28 countries):
- Drug-resistant: offer a surgical evaluation to every patient with drug-resistant epilepsy as soon as resistance is established, whatever the epilepsy type or duration.
- Not yet drug-resistant: consider referral for children seizure-free on 1–2 medications who have a lesion in noneloquent cortex.
- ILAE position 2025: reaffirmed early surgery for drug-sensitive lesional focal epilepsy.
2. Why operate early
- Development is at stake.
- Unilateral temporal lobe epilepsy (79 children) :
- IQ below 79: 57%.
- Onset in the first year of life: 82.4%, a critical early window.
- Surgery in infancy (under 3 years) :
- Seizures: 17 of 24 became seizure-free.
- Development: developmental quotients improved, most in younger infants and those with epileptic spasms.
- Strongest predictor: preoperative development predicted postoperative development.
- Seizure freedom falls with delay. A delay from drug resistance to evaluation independently reduced seizure freedom .
- The 2026 AES/CNS guideline: anyone whose epilepsy is drug-resistant should be able to reach a tertiary epilepsy center .
3. Etiologies
- International pediatric survey (543 children, 2004) :
- cortical dysplasia: 42%;
- tumors: 19%;
- atrophic lesions and strokes: 10%;
- infantile spasms: 4%;
- Rasmussen encephalitis and Sturge–Weber: 3% each;
- Landau–Kleffner syndrome or ESES (electrical status epilepticus in sleep): under 2%;
- vascular lesions: 1.5%.
- Seizure onset in the first year of life: 46%.
- Children under 4: usually daily seizures from dysplasia, treated with multilobar or hemispheric surgery.
- Cortical dysplasia (see Focal Cortical Dysplasia):
- The commonest pediatric substrate.
- Hard to localize: 33–50% have nonlocalized scalp EEG and a normal MRI.
- FDG-PET is positive in 75–90%.
- Resection matters: about 80% are seizure-free after complete resection vs. 20% after incomplete.
- Type II presents younger, with more frequent and extratemporal seizures. Type I is more often temporal and MRI-negative.
- Low-grade epilepsy-associated tumors (ganglioglioma, DNET): see Supratentorial LGG.
- Tuberous sclerosis :
- Multiple tubers and bilateral EEG are not a contraindication.
- Staged invasive monitoring (often three stages, bilateral when needed) in 25 young children:
- 68% Engel I at a mean of 28 months;
- 4 of 5 children first rejected for multifocality became seizure-free.
- Hemispheric syndromes (see Hemispherectomy):
- Rasmussen encephalitis;
- hemimegalencephaly;
- Sturge–Weber;
- perinatal infarction.
- Hypothalamic hamartoma: gelastic seizures. Treat with LITT; see LITT in Epilepsy Surgery.
4. Outcomes
- Seizure freedom:
- Pediatric meta-analysis (258 studies) :
- Over time: 64.8% at 1 year, 60.3% at 5 years and 39.7% at 10 years.
- By procedure: highest after hemispheric surgery, then temporal, then extratemporal.
- By pathology: highest for tumors, lower for malformations of cortical development.
- Lower odds: incomplete resection (OR 0.13) and nonlesional epilepsy (OR 0.54).
- Long-term, all ages (76 studies of 5 years or more) :
- Seizure-free: 66% after temporal, 46% after occipital or parietal, 27% after frontal resection.
- Callosotomy: 35% free of the most disabling seizures.
- Medications (long-term meta-analysis) :
- Off all medication: about 20%; monotherapy 41%.
- Children had better medication outcomes than adults.
- Development, behavior and quality of life:
- Pediatric RCT : surgery improved:
- behavior (Child Behavior Checklist);
- quality of life;
- social quotient;
- seizure severity.
- IQ: no significant change at 12 months.
- Long-term: IQ was unchanged by surgery, and memory outcome was linked to seizure freedom and side of temporal resection .
- Risks:
- Pediatric RCT (all lesion types): serious adverse events in 33%, including hemiparesis in 26%. These were the anticipated deficits for the region resected .
- Region-specific deficits are covered in each procedure chapter:
- quadrantanopia and memory after temporal surgery;
- hemiparesis and the supplementary motor area syndrome after frontal surgery;
- disconnection syndrome after callosotomy.
Related topics
- Temporal Lobe Epilepsy Surgery: the most common and rewarding operation.
- Extratemporal Epilepsy Surgery: resection outside the temporal lobe.
- Intracranial EEG: SEEG and grids.
- Brain Mapping: surgery in eloquent cortex.
- Corpus Callosotomy: palliative disconnection.
- Epilepsy in TSC: tuberous sclerosis surgical strategy.
- Cerebral Cavernous Malformations in Children: lesional epilepsy from cavernomas.
- Encephalitis: Neurosurgical Implications: seizure surgery after encephalitis.
- Neurosurgical Delivery of Therapies for Inherited Metabolic and Genetic Brain Disorders: stereotactic, intraventricular and intrathecal delivery of genetic therapies.
- Vagus Nerve Stimulator Implantation: step-by-step procedure.
- Corpus Callosotomy: Procedure: step-by-step procedure.
- Hemispherectomy and Hemispherotomy: Procedure: step-by-step procedure.
- Thalamic Deep Brain Stimulation for Epilepsy: Procedure: step-by-step procedure.
- Responsive Neurostimulation (RNS) Placement: step-by-step procedure.
References
- Dwivedi R, Ramanujam B, Chandra PS, et al. Surgery for drug-resistant epilepsy in children. N Engl J Med 2017;377(17):1639–1647. doi:10.1056/NEJMoa1615335. PMID 29069568. verified
- Samanta D, Caraway AR, Knox AT, et al. Delayed surgical evaluation after drug-resistant epilepsy diagnosis worsens outcomes in children: a multicenter study. Neurol Clin Pract 2026;16(5):e200641. doi:10.1212/CPJ.0000000000200641. PMID 42479984. verified
- Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010;51(6):1069–1077. doi:10.1111/j.1528-1167.2009.02397.x. PMID 19889013. verified
- Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342(5):314–319. doi:10.1056/NEJM200002033420503. PMID 10660394. verified
- Berg AT, Shinnar S, Levy SR, et al. Early development of intractable epilepsy in children: a prospective study. Neurology 2001;56(11):1445–1452. doi:10.1212/wnl.56.11.1445. PMID 11402099. verified
- Spooner CG, Berkovic SF, Mitchell LA, et al. New-onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome. Neurology 2006;67(12):2147–2153. doi:10.1212/01.wnl.0000248189.93630.4f. PMID 17082466. verified
- Jehi L, Jette N, Kwon CS, et al. Timing of referral to evaluate for epilepsy surgery: expert consensus recommendations from the Surgical Therapies Commission of the International League Against Epilepsy. Epilepsia 2022;63(10):2491–2506. doi:10.1111/epi.17350. PMID 35842919. verified
- Englot DJ, Jehi L. ILAE position on early surgery for drug sensitive lesional focal epilepsy. Brain 2025;148(11):e108. doi:10.1093/brain/awaf266. PMID 40681963. verified
- Cormack F, Cross JH, Isaacs E, et al. The development of intellectual abilities in pediatric temporal lobe epilepsy. Epilepsia 2007;48(1):201–204. doi:10.1111/j.1528-1167.2006.00904.x. PMID 17241230. verified
- Loddenkemper T, Holland KD, Stanford LD, et al. Developmental outcome after epilepsy surgery in infancy. Pediatrics 2007;119(5):930–935. doi:10.1542/peds.2006-2530. PMID 17473093. verified
- Jobst BC, Bergey G, Roldán-Benítez YM, et al. American Epilepsy Society/Congress of Neurological Surgeons epilepsy surgery clinical practice guideline. Epilepsy Curr 2026. doi:10.1177/15357597261465347. PMID 42948139. verified
- Harvey AS, Cross JH, Shinnar S, et al. Defining the spectrum of international practice in pediatric epilepsy surgery patients. Epilepsia 2008;49(1):146–155. doi:10.1111/j.1528-1167.2007.01421.x. PMID 18042232. verified
- Lerner JT, Salamon N, Hauptman JS, et al. Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia 2009;50(6):1310–1335. doi:10.1111/j.1528-1167.2008.01998.x. PMID 19175385. verified
- Weiner HL, Carlson C, Ridgway EB, et al. Epilepsy surgery in young children with tuberous sclerosis: results of a novel approach. Pediatrics 2006;117(5):1494–1502. doi:10.1542/peds.2005-1206. PMID 16651302. verified
- Widjaja E, Jain P, Demoe L, et al. Seizure outcome of pediatric epilepsy surgery: systematic review and meta-analyses. Neurology 2020;94(7):311–321. doi:10.1212/WNL.0000000000008966. PMID 31996452. verified
- Téllez-Zenteno JF, Dhar R, Wiebe S. Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis. Brain 2005;128(Pt 5):1188–1198. doi:10.1093/brain/awh449. PMID 15758038. verified
- Téllez-Zenteno JF, Dhar R, Hernandez-Ronquillo L, Wiebe S. Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects. Brain 2007;130(Pt 2):334–345. doi:10.1093/brain/awl316. PMID 17124190. verified
Verification (2026-11-16):
- Each reference's authors, title, journal, year, volume, pages, DOI and PMID were checked on PubMed, and every number against the PubMed abstract.
- Reference 8 has no abstract; it is cited only for the ILAE position it states in its title.
Caveats:
- Organization follows Dr. Hauptman's ESIC lecture ("Surgery for Epilepsy in Children").
- Several of the lecture's older citations were not re-verified for this chapter and are not cited here, for example the seizure-recurrence risks after a first seizure and the mortality figures.
- The lecture's "~60%" IQ figure is given here as the abstract's 57% .
- References 4, 16 and 17 include adults.
- The figure is an original schematic.